Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccinationJoana Barros‐Martins(Medizinische Hochschule Hannover), Georg M. N. Behrens(Medizinische Hochschule Hannover)Nature MedicineJuly 14, 202110.1038/s41591-021-01449-9Cited by 463SaveCiteExport RISWatch citationsRelated PapersNational medical specialty guidelines of HIV indicator conditions in Europe lack adequate HIV testing recommendations: a systematic guideline review|Eurosurveillance|2022|32